SOURCE: annual_report_text (1).txt
CHUNK: 817 of 1106
SIZE: 672 characters
PREVIOUS: chunk_0816_annual_report_text (1).txt
NEXT: chunk_0818_annual_report_text (1).txt
------------------------------
aire). The overall investment by all partners in NHa is 
over EUR 60 million, in equity and bond 
financing 
(guaranteed 
by 
the 
Normandy 
Region). IBAs contribution amounted to EUR 6 
million in equity and EUR 1,5 million in 
convertible Bond financing (see note 6.2.3). IBAs investment also includes the sale of 
intellectual property related to the Cyclone400 
cyclotron to NHa. The gain on this transaction 
amounted to EUR 5 million which was reduced 
by EUR 2 million (39.81%) for unrealized gain in 
2019. IBA has no capital commitments as at December 
31, 2022 and December 31, 2023 to participate 
in any potential future funding of Normandy 
Hadrontherapy SAS.